Clyde Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.12M

  • Investors
  • 5

Clyde Biosciences General Information

Description

Developer of cell analysis solutions designed to eliminate risk at an earlier stage in the development of diseases. The company's platform generates human-relevant cardiomyocyte functional data for the development of new medicines.

Contact Information

Website
www.clydebio.com
Formerly Known As
Dunwilco (1739)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • BioCity Scotland
  • Bo'Ness Road, Lanarkshire
  • Newhouse ML1 5UH
  • Scotland, United Kingdom
+44 01638 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clyde Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 28-Mar-2018 $1.12M 00.000 Completed Generating Revenue
5. Early Stage VC (Series A) 20-Mar-2015 00.000 00.000 00.00 Completed Startup
4. Grant 01-Sep-2014 000.00 Completed Startup
3. Grant 13-Sep-2013 000.00 Completed Startup
2. Early Stage VC 22-Aug-2012 Completed Startup
1. Spin-Off 01-Jan-2012 Completed Startup
To view Clyde Biosciences’s complete valuation and funding history, request access »

Clyde Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell analysis solutions designed to eliminate risk at an earlier stage in the development of diseases. The
Other Healthcare Technology Systems
Newhouse, United Kingdom
8 As of 2022
00.000
0000000000 0 00.000

000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000000000000
Boston, MA
000 As of 0000
0000 0000-00-00
000000&0

000000

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
0000 000000000
Wilmington, MA
00000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clyde Biosciences Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Invicro Formerly VC-backed Boston, MA 000 000000&0
0000000 00000 0000 Formerly PE-Backed Wilmington, MA 00000 00.000 000000000 00.000
0000000000 Formerly VC-backed Fremont, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed New York, NY 00 000.00 000000000000 000.00
To view Clyde Biosciences’s complete competitors history, request access »

Clyde Biosciences Executive Team (8)

Name Title Board Seat Contact Info
Richard Henderson Chief Executive Officer & Chief Financial Officer
Godfrey Smith Co-Founder and Chief Scientific Officer
Amena Akhtar Executive, Finance
Mark Bryant Ph.D Chief Business Officer
Francis Burton Co-Founder & Head of Software & Modeling
You’re viewing 5 of 8 executive team members. Get the full list »

Clyde Biosciences Board Members (4)

Name Representing Role Since
Alan Johnston Self Chairman 000 0000
Andrew Dunlop Self Board Member 000 0000
Peter Finan Ph.D Epidarex Capital Board Member 000 0000
Sinclair Dunlop Epidarex Capital Board Member 000 0000
To view Clyde Biosciences’s complete board members history, request access »

Clyde Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clyde Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Epidarex Capital Venture Capital Minority 000 0000 000000 0
University of Glasgow Endowment Limited Partner Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
To view Clyde Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial